Peter Junker
- Rheumatology top 0.2%
- Rheumatoid Arthritis Research and Therapies 65
- Systemic Lupus Erythematosus Research 43
- Spondyloarthritis Studies and Treatments 11
- Immunology top 2%
- Hematology top 2%
- Autoimmune and Inflammatory Disorders Research 12
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 10
- Myeloproliferative Neoplasms: Diagnosis and Treatment 9
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research 12
-
- Monoclonal and Polyclonal Antibodies Research 19
- Co-authors
- Kim Hørslev‐PetersenAnne VossAnders Jørgen SvendsenMikkel ØstergaardMerete Lund HetlandHanne LindegaardHelle LaustrupI. Lorenzen
- Cited by
- RheumatologyImmunologyHematology
- Journals
- Scandinavian Journal of Rheumatology (19 papers)Annals of the Rheumatic Diseases (19 papers)Arthritis Research & Therapy (7 papers)
- Partner nations
- DenmarkUnited StatesSweden
In The Last Decade
Peter Junker
175 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 135
- Rheumatology 2.0k
- Immunology 1.3k
- Hematology 620
- Genetics 332
- Immunology and Allergy 142
Countries citing papers authored by Peter Junker
This map shows the geographic impact of Peter Junker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Junker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Junker more than expected).
Fields of papers citing papers by Peter Junker
This network shows the impact of papers produced by Peter Junker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Junker. The network helps show where Peter Junker may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Junker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 7 | |
| 3 | 2023 | 7 | |
| 4 | 2022 | 2 | |
| 5 | 2022 | 2 | |
| 6 | 2021 | 10 | |
| 7 | 2021 | 6 | |
| 8 | 2020 | 8 | |
| 9 | 2019 | 6 | |
| 10 | 2018 | 18 | |
| 11 | 2016 | 6 | |
| 12 | [Myopathy in a patient during simvastatin and fluconazole treatment]. | 2016 | 1 |
| 13 | 2016 | 33 | |
| 14 | 2013 | 21 | |
| 15 | M-Ficolin, an activator of the complement system is the strongest predictor of both DAS28 remission and low disease activity in a cohort of 180 early DMARD naïve rheumatoid arthritis patients followed in The OPERA-study. | 2012 | 1 |
| 16 | Adalimumab Added to Methotrexate and Intra-Articular Glucocorticoid Increases Remission Rates At One Year In Early, DMARD-Naïve Patients with Rheumatoid Arthritis—An Investigator-Initiated Randomized, Controlled, Double-Blinded Study | 2011 | 3 |
| 17 | 2011 | 15 | |
| 18 | LAND PROPERTY DISTRIBUTIONS AS A MEANS FOR ENHANCING SUSTAINABLE BUILDING. THE LUNDBY COMPETITION IN GOTHENBURG, SWEDEN, AS AN EXAMPLE | 2008 | 0 |
| 19 | Is it possible to stop radiographic progression with conventional treatment in early rheumatoid arthritis?: 2 years results from the CIMESTRA study | 2007 | 1 |
| 20 | 1995 | 42 |
About Peter Junker
Peter Junker is a scholar working on Rheumatology, Hematology, Immunology, Immunology and Allergy and Genetics, having authored 180 papers that have together received 4.0k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (65 papers), Systemic Lupus Erythematosus Research (43 papers), Monoclonal and Polyclonal Antibodies Research (19 papers), Autoimmune and Inflammatory Disorders Research (12 papers), Cell Adhesion Molecules Research (12 papers), Spondyloarthritis Studies and Treatments (11 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers). The work is most often cited by research in Rheumatology (2.0k citations), Immunology (1.3k citations), Hematology (620 citations), Genetics (332 citations) and Immunology and Allergy (142 citations). Peter Junker has collaborated with scholars based in Denmark, United States and Sweden. Frequent co-authors include Kim Hørslev‐Petersen, Anne Voss, Anders Jørgen Svendsen, Mikkel Østergaard, Merete Lund Hetland, Hanne Lindegaard, Helle Laustrup, I. Lorenzen, Kristian Stengaard‐Pedersen and Hans Carl Hasselbalch. Their work appears in journals such as Scandinavian Journal of Rheumatology, Annals of the Rheumatic Diseases, Arthritis Research & Therapy, Lupus and The Journal of Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.